Awareness, discussion and non-prescribed use of HIV pre-exposure prophylaxis among persons living with HIV/AIDS in Italy: a Nationwide, cross-sectional study among patients on antiretrovirals and their treating HIV physicians

[1]  R. Gandhi.  Preexposure Prophylaxis for the Prevention of HIV , 2018 .

[2]  S. McCormack,et al.  Highlights of the 2017 European AIDS Clinical Society (EACS) Guidelines for the treatment of adult HIV‐positive persons version 9.0 , 2018, HIV medicine.

[3]  B. Spire,et al.  Informal pre‐exposure prophylaxis use in France: results from the Flash PrEP survey (2014) , 2017, HIV medicine.

[4]  S. Kurtz,et al.  Preliminary evidence of HIV seroconversion among HIV-negative men who have sex with men taking non-prescribed antiretroviral medication for HIV prevention in Miami, Florida, USA. , 2016, Sexual health.

[5]  G. Prati,et al.  PEP and TasP Awareness among Italian MSM, PLWHA, and High-Risk Heterosexuals and Demographic, Behavioral, and Social Correlates , 2016, PloS one.

[6]  Sheena McCormack,et al.  Pre-exposure prophylaxis to prevent the acquisition of HIV-1 infection (PROUD): effectiveness results from the pilot phase of a pragmatic open-label randomised trial , 2016, The Lancet.

[7]  David Thompson,et al.  On-Demand Preexposure Prophylaxis in Men at High Risk for HIV-1 Infection. , 2015, The New England journal of medicine.

[8]  Mark D M Davis.  After the clinic? Researching sexual health technology in context , 2015, Culture, health & sexuality.

[9]  P. Keogh,et al.  Pharmaceutical HIV prevention technologies in the UK: six domains for social science research , 2015, AIDS care.

[10]  C. Pradier,et al.  Preexposure prophylaxis (PrEP) of HIV infection in France: A nationwide cross-sectional study (PREVIC study) , 2014, AIDS care.

[11]  C. Hendrix,et al.  Antiretroviral prophylaxis for HIV infection in injecting drug users in Bangkok, Thailand (the Bangkok Tenofovir Study): a randomised, double-blind, placebo-controlled phase 3 trial , 2013, The Lancet.

[12]  G. Ippolito,et al.  Attitude towards antiretroviral pre-exposure prophylaxis (PrEP) prescription among HIV specialists , 2013, BMC Infectious Diseases.

[13]  J. D. de Wit,et al.  The Informal Use of Antiretrovirals for Preexposure Prophylaxis of HIV Infection Among Gay Men in Australia , 2013, Journal of acquired immune deficiency syndromes.

[14]  A. Monforte,et al.  Inconsistent condom use among HIV-positive women in the “Treatment as Prevention Era”: data from the Italian DIDI study , 2013, Journal of the International AIDS Society.

[15]  John T Brooks,et al.  Antiretroviral preexposure prophylaxis for heterosexual HIV transmission in Botswana. , 2012, The New England journal of medicine.

[16]  James D. Campbell,et al.  Antiretroviral prophylaxis for HIV prevention in heterosexual men and women. , 2012, The New England journal of medicine.

[17]  David V Glidden,et al.  Preexposure chemoprophylaxis for HIV prevention in men who have sex with men. , 2010, The New England journal of medicine.

[18]  P. Sullivan,et al.  Knowledge and use of preexposure and postexposure prophylaxis among attendees of Minority Gay Pride events, 2005 through 2006. , 2007, Journal of acquired immune deficiency syndromes.